Join

Compare · CI vs SPNE

CI vs SPNE

Side-by-side comparison of The Cigna Group (CI) and SeaSpine Holdings Corporation (SPNE): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CI and SPNE operate in Medical Specialities (Health Care), so they compete in similar markets.
  • CI is the larger of the two at $71.62B, about 172.5x SPNE ($415.1M).
  • CI has hit the wire 9 times in the past 4 weeks while SPNE has been quiet.
  • CI has more recent analyst coverage (25 ratings vs 5 for SPNE).
MetricCISPNE
Company
The Cigna Group
SeaSpine Holdings Corporation
Price
$270.88-0.67%
$9.52+8.18%
Market cap
$71.62B
$415.1M
1M return
-3.03%
-
1Y return
-13.08%
-
Industry
Medical Specialities
Medical Specialities
Exchange
NYSE
NASDAQ
IPO
News (4w)
9
0
Recent ratings
25
5
CI

The Cigna Group

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's U.S. Medical segment offers commercial products and services, including medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as Medicaid plans; and individual health insurance plans to on and off the public exchanges. Its International Markets segment offers health coverage, hospitalization, dental, critical illness, personal accident, term life, medical cost containment, and variable universal life products, as well as health care benefits to mobile employees of multinational organizations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

SPNE

SeaSpine Holdings Corporation

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. The company provides orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. Its orthobiologics products include demineralized bone matrices (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. The company also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and demineralized bone matrices. Its spinal implant portfolio comprises products for spinal decompression, alignment, and stabilization that are used to facilitate fusion in degenerative, minimally invasive surgery, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical spine. The company has development and licensing agreement with restor3d, Inc. and 7D Surgical, Inc. to develop 3D-printed interbody devices. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.

Latest CI

Latest SPNE